HZSY(SH:600191) Ge Long Hui A P P·2025-12-18 09:27Core Viewpoint - The company plans to establish a wholly-owned subsidiary, Baotou Henglu Biotechnology Co., Ltd., with a registered capital of 10 million yuan, to advance its development strategy of "innovation-driven, diversified layout, and promoting industrial upgrading" [1] Group 1: Company Strategy - The establishment of the new subsidiary aims to enhance the company's product offerings, including the development of skincare products using xanthan gum, an important additive in cosmetics [1] - The subsidiary will also focus on launching convenient nutritional meal replacement products, such as weight loss meal replacement powder and nutritional beverages, utilizing resistant dextrin, a soluble dietary fiber [1] - The development of these new products is expected to help the company extend its industrial chain and enhance its product value chain [1] Group 2: Technological Collaboration - The new subsidiary will leverage existing resources, including the Baotou Huazi Synthetic Biology and Microbial Modification Technology Academician Workstation, and collaborate with the Chinese Academy of Sciences' Environmental Biotechnology Key Laboratory to establish technology demonstration and co-creation bases [1] - The company plans to work closely with industry experts, scholars, and research institutions to monitor cutting-edge technologies and industry trends in biological fermentation and health products [1] - This initiative aligns with the company's strategic planning for industrial upgrading and development in the health industry [1]